Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.

Ma SJ, Oladeru OT, Miccio JA, Iovoli AJ, Hermann GM, Singh AK.

JAMA Netw Open. 2019 Aug 2;2(8):e199126. doi: 10.1001/jamanetworkopen.2019.9126.


Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery.

Salazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ.

JAMA Oncol. 2017 May 1;3(5):610-619. doi: 10.1001/jamaoncol.2016.5829.


Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer.

Ma SJ, Hermann GM, Prezzano KM, Serra LM, Iovoli AJ, Singh AK.

Cancer Med. 2019 Mar;8(3):939-952. doi: 10.1002/cam4.1967. Epub 2019 Jan 16.


Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.

Amini A, Waxweiler TV, Brower JV, Jones BL, McDermott JD, Raben D, Ghosh D, Bowles DW, Karam SD.

JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110. doi: 10.1001/jamaoto.2016.2168.


Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database.

Seaton M, Hanna A, Boutros C, Hanna N.

Ther Adv Med Oncol. 2019 May 3;11:1758835919842438. doi: 10.1177/1758835919842438. eCollection 2019.


Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.

Wakeam E, Acuna SA, Leighl NB, Giuliani ME, Finlayson SRG, Varghese TK, Darling GE.

Lung Cancer. 2017 Jul;109:78-88. doi: 10.1016/j.lungcan.2017.04.021. Epub 2017 May 1.


Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.

Ma SJ, Iovoli AJ, Hermann GM, Prezzano KM, Singh AK.

Cancer Med. 2019 Aug;8(9):4110-4123. doi: 10.1002/cam4.2326. Epub 2019 Jun 10.


Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.

Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM Jr, Datta J.

Ann Surg Oncol. 2017 Dec;24(13):3926-3933. doi: 10.1245/s10434-017-6095-9. Epub 2017 Sep 26.


Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.

Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE.

Cancer. 2017 May 15;123(6):967-976. doi: 10.1002/cncr.30439. Epub 2016 Nov 7.


Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.

Sun Z, Adam MA, Kim J, Nussbaum DP, Benrashid E, Mantyh CR, Migaly J.

Dis Colon Rectum. 2016 Feb;59(2):87-93. doi: 10.1097/DCR.0000000000000518.


Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.

Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL.

Cancer. 2015 Dec 1;121(23):4141-9. doi: 10.1002/cncr.29652. Epub 2015 Aug 17.


Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.

Mirkin KA, Greenleaf EK, Hollenbeak CS, Wong J.

Cancer. 2016 Oct;122(19):2979-87. doi: 10.1002/cncr.30163. Epub 2016 Jun 21.


Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.

Goodman CR, Seagle BL, Friedl TWP, Rack B, Lato K, Fink V, Cristofanilli M, Donnelly ED, Janni W, Shahabi S, Strauss JB.

JAMA Oncol. 2018 Aug 1;4(8):e180163. doi: 10.1001/jamaoncol.2018.0163. Epub 2018 Aug 9.


Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, Laheru DA, Farnell MB, Swartz MJ, Gunderson LL, Miller RC.

Ann Surg Oncol. 2010 Apr;17(4):981-90. doi: 10.1245/s10434-009-0743-7. Epub 2010 Jan 20.


Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.

Gabriel E, Attwood K, Du W, Tuttle R, Alnaji RM, Nurkin S, Malhotra U, Hochwald SN, Kukar M.

JAMA Surg. 2016 Mar;151(3):234-45. doi: 10.1001/jamasurg.2015.4068.


Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.

Daskalakis K, Karakatsanis A, Hessman O, Stuart HC, Welin S, Tiensuu Janson E, Öberg K, Hellman P, Norlén O, Stålberg P.

JAMA Oncol. 2018 Feb 1;4(2):183-189. doi: 10.1001/jamaoncol.2017.3326.


An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.

Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43.


Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.

Datta J, Ecker BL, Neuwirth MG, Geha RC, Fraker DL, Roses RE, Karakousis GC.

Surg Oncol. 2017 Jun;26(2):117-124. doi: 10.1016/j.suronc.2017.01.008. Epub 2017 Feb 2. Review.


Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection.

Dossa F, Acuna SA, Rickles AS, Berho M, Wexner SD, Quereshy FA, Baxter NN, Chadi SA.

JAMA Oncol. 2018 Jul 1;4(7):930-937. doi: 10.1001/jamaoncol.2017.5597.

Supplemental Content

Support Center